Chemoprophlaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

Chemoprophlaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

<br><strong>Background<br></strong> Chemoprophylactics against emerging epidemic and pandemic infectious diseases offer potential for prevention but require efficacy and safety analysis before widespread use can be recommended. Chemoprophylaxis with repurposed drugs enable d...

Full description

Bibliographic Details
Main Authors:	Manoharan, L, Olliaro, P, Horby, P, Watson, C
Format:	Journal article
Language:	English
Published:	BMC 2021

Similar Items

A living systematic review protocol for COVID-19 clinical trial registrations
by: Maguire, BJ, et al.
Published: (2020)

Baseline results of a living systematic review for COVID-19 clinical trial registrations
by: Maguire, BJ, et al.
Published: (2020)

Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: a systematic review
by: Manoharan, L, et al.
Published: (2021)

Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems
by: McCabe, R, et al.
Published: (2023)

Design of vaccine efficacy trials for priority emerging and epidemic diseases
by: Watson, C, et al.
Published: (2019)

COVID-19 epidemic in Malaysia: Epidemic progression, challenges, and response
by: Jamal Hisham, Hashim, et al.
Published: (2021)

Monitoring respiratory infections in covid-19 epidemics
by: Chan, KH, et al.
Published: (2020)

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions
by: McLean, ARD, et al.
Published: (2022)

Crowding and the shape of COVID-19 epidemics
by: Rader, B, et al.
Published: (2020)

Inequality shaping epidemics, epidemics reproducing inequality: intersectionality and COVID-19
by: Chan, G, et al.
Published: (2021)

Performance of different clinical trial designs to evaluate treatments during an epidemic
by: Brueckner, M, et al.
Published: (2018)

Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
by: de Souza, WM, et al.
Published: (2020)

Establishing COVID-19 trials at scale and pace: experience from the RECOVERY trial
by: Peto, L, et al.
Published: (2022)

Reliability of trial information across registries for trials with multiple registrations: a systematic review
by: Speich, B, et al.
Published: (2021)

The scale and dynamics of COVID-19 epidemics across Europe
by: Dye, C, et al.
Published: (2020)

COVID-19 transmission dynamics underlying epidemic waves in Kenya
by: Brand, SPC, et al.
Published: (2021)

What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
by: Michelen, M, et al.
Published: (2020)

Epidemic SI COVID-19 modeling in LMICs: accompanying commentary
by: Pan-ngum, W, et al.
Published: (2022)

Modernising epidemic science: enabling patient-centred research during epidemics
by: Rojek, A, et al.
Published: (2016)

Insights from clinical research completed during the west Africa Ebola virus disease epidemic
by: Rojek, A, et al.
Published: (2017)

Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
by: Murali, M, et al.
Published: (2023)

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – authors' reply
by: Peto, L, et al.
Published: (2024)

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic
by: Rojek, A, et al.
Published: (2017)

Characterising long COVID: a living systematic review
by: Michelen, M, et al.
Published: (2021)

Evolution of an epidemic: understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality
by: Laing, R, et al.
Published: (2024)

The chemical and biological non-proliferation regime after the COVID-19 epidemic
by: Shang, Lijun
Published: (2021)

The effect of human mobility and control measures on the COVID-19 epidemic in China
by: Kraemer, MUG, et al.
Published: (2020)

The discipline and resistance of the display politics in China during the COVID-19 epidemic
by: Lu, Xinyi
Published: (2023)

Age groups that sustain resurging COVID-19 epidemics in the United States
by: Monod, M, et al.
Published: (2021)

Staging the COVID-19 pandemic: revisiting Rosenberg's dramaturgical form of epidemics
by: English, S
Published: (2021)

Reliance on scientists and experts during an epidemic: Evidence from the COVID-19 outbreak in Italy
by: Battiston, P, et al.
Published: (2020)

What are the long-term symptoms and complications of COVID-19: A protocol for a living systematic review
by: Michelen, M, et al.
Published: (2020)

Interpretations of studies on SARS-CoV-2 vaccination and post-acute COVID-19 sequelae
by: Gonçalves, BP, et al.
Published: (2024)

Lessons for preparedness and reasons for concern from the early COVID-19 epidemic in Iran
by: Ghafari, M, et al.
Published: (2021)

How will country-based mitigation measures influence the course of the COVID-19 epidemic?
by: Anderson, RM, et al.
Published: (2020)

Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic
by: Richard, Q, et al.
Published: (2021)

Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions
by: Ragonnet-Cronin, M, et al.
Published: (2021)

School closures during COVID-19: an overview of systematic reviews
by: Hume, S, et al.
Published: (2023)

The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing
by: Xavier, J, et al.
Published: (2020)

Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins.
by: Horby, P
Published: (2002)